Honasa Consumer Acquires 58% Stake in Fluence Pharma, Enters Nutraceuticals
Mamaearth parent Honasa Consumer takes 58% majority stake in Fluence Pharma, extending its 'inside-out' beauty strategy into nutraceuticals via patented Cyclical Nutrition Therapy and dermatologist-led distribution channels.
What happened
Honasa Consumer acquires 58% majority stake in Fluence Pharma, entering the nutraceuticals space with patented Cyclical Nutrition Therapy and dermatologist-led
Key facts
- 58% stake
Why this matters
Deal template—58% stake plus patented Cyclical Nutrition Therapy IP and dermatologist channels—sets a benchmark for beauty-adjacent nutraceutical roll-ups in the subcontinent.